Identity
- Security key
- 22667
- Ticker
- TOVX
- Type
- CS — Common Stock
- Exchange
- NYSE American, LLC(XASE)
- Venue group
- NYSE
- Operating MIC
- XNYS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 1993-04-05
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- TOVX
Detail
Enriched 2026-08-14 20:47
- Market cap
- $11,014,240.32
- Shares outstanding (class)
- 45,892,668
- Shares outstanding (weighted)
- 45,892,668
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 16
- Location
- ROCKVILLE, MD
- Homepage
- https://www.therivabio.com
- Description
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system. Product Candidates includes SYN-004 (ribaxamase) and SYN-020.